Overview

Effect of Itraconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects

Status:
Completed
Trial end date:
2019-11-30
Target enrollment:
Participant gender:
Summary
The study will assess the effect of multiple oral doses of itraconazole on the single dose pharmacokinetic parameters of pyrotinib in healthy Chinese subjects. The safety of pyrotinib alone and when co-administered with itraconazole will also be assessed.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Itraconazole